Ligand Pharmaceuticals
LGND
#2813
Rank
NZ$10.53 B
Marketcap
NZ$526.87
Share price
-2.70%
Change (1 day)
44.01%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2026 (TTM): NZ$4.48

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$4.69. In 2025 the company made an earnings per share (EPS) of NZ$11.42 an increase over its 2024 EPS that were of NZ-$0.09064.

EPS history for Ligand Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$4.48-60.75%
2025NZ$11.42-12700%
2024NZ-$0.09064-101.73%
2023NZ$5.24-245.96%
2022NZ-$3.59-157.23%
2021NZ$6.27-2571.43%
2020NZ-$0.25-100.46%
2019NZ$55.49353.48%
2018NZ$12.241025%
2017NZ$1.09-700%
2016NZ-$0.18-100.87%
2015NZ$20.951859.32%
2014NZ$1.075.36%
2013NZ$1.028.0704505322479E+18%
2012NZ$0.0000000000

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.11 157.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$1.29-72.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$56.00 1,092.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$31.50 571.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ-$2.56-154.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.80-61.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.19 74.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.22 11.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
NZ-$0.65-113.90%๐Ÿ‡บ๐Ÿ‡ธ USA